ProShare Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-12,044
| Closed | -$56K | – | 2332 |
|
|
2021
Q4 | $56K | Sell |
12,044
-32
| -0.3% | -$149 | ﹤0.01% | 2275 |
|
|
2021
Q3 | $103K | Sell |
12,076
-2,695
| -18% | -$23K | ﹤0.01% | 1913 |
|
|
2021
Q2 | $242K | Buy |
14,771
+1,775
| +14% | +$29.1K | ﹤0.01% | 2030 |
|
|
2021
Q1 | $287K | Buy |
12,996
+2,212
| +21% | +$48.8K | ﹤0.01% | 1831 |
|
|
2020
Q4 | $334K | Buy |
+10,784
| New | +$334K | ﹤0.01% | 1543 |
|